Morocco can become a leader in medical research
On April 4, Decree No. 2.22.159 was published in the Moroccan official journal for the application of the law relating to the legal use of cannabis. An opportunity for the Kingdom that could benefit long-despised farmers. The issue of the necessary licenses for the legitimate use of this plant, which has many qualities, remains to be regulated.
This is a major step forward that Morocco has just made to the delight of farmers and pharmaceutical manufacturers thanks to the many economic advantages represented by the legalization of the use of cannabis. The annual growth rate of the medical market is 30% and the demand for the global medical cannabis market “keeps growing”.
With the legal framework in place, Law No. 13.21, specifies the procedures for obtaining licenses, the approval of seeds and plants, the methods of harvesting and destroying impurities, the declaration of damage and the process for license discounts. The Ministries of the Interior, Health and Agriculture have just promulgated decrees specifying the details of the issuance of licenses in order to practice cannabis-related activities.
« How to be successful in Medical cannabis in Morocco“. This is the question that Pr Redouane Rabii, president of the Moroccan Consultative Association for the Use of Cannabis (AMCUC), tried to answer as part of the 1st National Congress on Therapeutic Innovation.
In his speech, the president of the AMCUC, affirmed that the legalization of therapeutic cannabis in Morocco offers a great opportunity to establish itself as a leading country in the field of research on medical cannabis, emphasizing the importance of establish an environment conducive to medical research while being in harmony with international standards and the vision of the Moroccan authorities.
The global medical cannabis market represents about 60% of the global legalized market, said Redouane Rabii. An index that allows Morocco to easily penetrate international markets thanks to its multiple advantages, including favorable natural and climatic conditions, proximity to emerging European and African markets, and abundant logistics capacities.
This is why Professor Rabii highlighted the importance of identifying alternative income-generating activities to end the illegal status of farmers so that they join the cultivation of therapeutic cannabis. It is also necessary to promote university degrees, develop training as well as clinical trials and other studies.
Aware of the therapeutic benefits of this plant, Pr. Rabii said that medical cannabis can treat many diseases that are currently incurable. In this sense, he cited a number of pathologies known to be sensitive to cannabis, such as Alzheimer's, amyotrophic lateral sclerosis, cancer, chronic pain, glaucoma, inflammation, migraine and nervous system degeneration.
That said, the specialist insisted on the importance of the standardization of medical Cannabis products, specifying that cannabis products approved for medical use must meet the very developed pharmaceutical industry standards and must be marked " BMI - Medical Grade" page (in French).
Morocco could benefit from the American and Israeli models “ very successful in this“, He clarified.
Six new decrees strengthen the legal framework for the legal use of cannabis, under Law No. 13.21 authorizing the legal uses of this plant, following their publication in the Official Bulletin (BO), Thursday June 2, 2022.
A joint order of the Minister of the Interior, the Minister of Health and Social Protection, the Minister of Agriculture, Maritime Fisheries, Rural Development, Water and Forests and the Minister of Industry and Commerce determines the maximum proportion of tetrahydrocannabinol (THC) in cannabis varieties authorized for cultivation and production.
Thus, the authorized rate of THC in Morocco must not exceed 1%, with the exception of plants and products intended for medical and pharmaceutical use, under articles 6 and 17 of law 13.21, relating to the legal uses of cannabis. .
By way of comparison, the THC level authorized in Europe recently went from 0,2% to 0,3%, and it must be less than 1% in Switzerland and the Czech Republic.
The other decrees relate in particular to the procedures for issuing authorizations to exercise cannabis-related activities, the model registers and the procedures for keeping them by the National Agency for the Regulation of Cannabis-Related Activities (ANRAC) and by the holders. authorizations for the exercise of activities relating to cannabis and on the conditions and procedures for the certification of cannabis seeds and plants by the agency.
It is also a question of fixing the models of contract of sale of the harvests of cannabis, of the report of delivery of the said harvests and of the reports of destruction of the surpluses of production of cannabis, its seeds, its plants, its crops and its products.
The decision is the result of a meeting on Thursday chaired by Interior Minister Abdelouafi Laftit and involved the board of directors of the National Agency for the Regulation of Cannabic Activities (ANRAC) which approved the organizational structure and the organization's budget for this year.
The agency will also set up the first processing and manufacturing cooperatives, made up exclusively of local producers.
En March, the Moroccan government has legalized the cultivation of cannabis for medical and industrial purposes in three northern provinces, namely Al-Hoceima, Chefchaouen and Taounate, located in the mountainous Rif region.
Other provinces could be added "depending on the interest shown by national and international investors in activities related to the cannabis production chain", according to the Ministry of the Interior.
En July last year, Morocco passed legalization legislating the production and export of cannabis, but the restrictions are undermining the competitiveness of the industry. Despite this, Morocco remains the world's largest producer of illicit cannabis.
according to Morocco World News, the progressive opening of the cannabis industry will offer the kingdom hundreds of new jobs and tax revenues for the Treasury, but Morocco faces strict restrictions which have prevented Moroccan companies from exporting to the international markets where medical cannabis is in high demand such as Germany and Israel.